BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 6, 2010
View Archived Issues
Nanotherapeutics submits IND to FDA for radiation exposure candidate
Read More
French scientists identify NTNG1 gene polymorphisms linked to alcohol and cocaine codependence
Read More
New MCH1 receptor antagonists claimed by sanofi-aventis
Read More
AstraZeneca's new TRPV1 antagonists inhibit capsaicin-evoked pain and flare
Read More
Atopaxar may reduce major cardiac events in subjects with ACS and CAD
Read More
Sanofi-aventis updates progress of second quarter 2010
Read More
Amgen discloses new selective inhibitors of hepatocyte growth factor receptor
Read More
Studies evaluate tamsulosin and doxazosin for urolithiasis
Read More
Czech scientists discover new antimicrobial peptides
Read More
Abbott presents new GlyT-1 inhibitors
Read More
Celldex to regain worldwide rights to rindopepimut from Pfizer
Read More
Merck & Co. describes novel gamma-secretase inhibitors
Read More
New activators of AMPK subunit alpha-1 claimed by Betagenon
Read More
INT-007 is bioequivalent to branded tablet for erectile dysfunction
Read More
Gilead submits MAA for fixed-dose Truvada/TMC-278 combination for HIV infection
Read More
Eisai launches Glufast in China for type 2 diabetes
Read More
Gynecologic Oncology Group to begin phase II trial of paclitaxel/ReoT3D combination
Read More
Johnson & Johnson submits MAA to EMA for TMC-278 for HIV infection
Read More
University of Rochester Medical Center begins study of muscular dystrophy therapeutics
Read More
Cladribine tablets are approved in Australia for MS
Read More
MSD and Faes Farma to market sitagliptin and sitagliptin/metformin in Spain
Read More
Levitra orodispersible tablet is approved in Europe for erectile dysfunction
Read More
EHDN supports statistical conclusions on MermaiHD trial's primary endpoint
Read More
ImmunoCellular Therapeutics presents update on ICT-107 and ICT-69
Read More
GSK investigates reports of narcolepsy following Pandemrix vaccination
Read More